ATE166344T1 - Schwefelderivate von imidazol, verfahren zu ihrer herstellung, zwischenprodukte, ihre verwendung als arzneimittel und sie enthaltende pharmazeutische zusammensetzungen - Google Patents
Schwefelderivate von imidazol, verfahren zu ihrer herstellung, zwischenprodukte, ihre verwendung als arzneimittel und sie enthaltende pharmazeutische zusammensetzungenInfo
- Publication number
- ATE166344T1 ATE166344T1 AT91401857T AT91401857T ATE166344T1 AT E166344 T1 ATE166344 T1 AT E166344T1 AT 91401857 T AT91401857 T AT 91401857T AT 91401857 T AT91401857 T AT 91401857T AT E166344 T1 ATE166344 T1 AT E166344T1
- Authority
- AT
- Austria
- Prior art keywords
- products
- imidazole
- production
- pharmaceutical compositions
- compositions containing
- Prior art date
Links
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 title 2
- 239000013067 intermediate product Substances 0.000 title 1
- 229940126601 medicinal product Drugs 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 150000003463 sulfur Chemical class 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 4
- 229910052739 hydrogen Inorganic materials 0.000 abstract 4
- 239000001257 hydrogen Substances 0.000 abstract 4
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 4
- 125000003342 alkenyl group Chemical group 0.000 abstract 3
- 125000003118 aryl group Chemical group 0.000 abstract 3
- 125000004435 hydrogen atom Chemical class [H]* 0.000 abstract 3
- 125000002252 acyl group Chemical group 0.000 abstract 2
- 125000000304 alkynyl group Chemical group 0.000 abstract 2
- -1 mercapto, formyl Chemical group 0.000 abstract 2
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 125000004414 alkyl thio group Chemical group 0.000 abstract 1
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 abstract 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 1
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/84—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Neurology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Vascular Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Epoxy Resins (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9008538A FR2664271B1 (fr) | 1990-07-05 | 1990-07-05 | Nouveaux derives soufres de l'imidazole, leur procede de preparation, les nouveaux intermediaires obtenus, leur application a titre de medicaments et les compositions pharmaceutiques les renfermant. |
| FR9104882A FR2675503B1 (fr) | 1991-04-19 | 1991-04-19 | Nouveaux derives soufres de l'imidazole, leur procede de preparation, les nouveaux intermediaires obtenus, leur application a titre de medicaments et les compositions pharmaceutiques les renfermant. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE166344T1 true ATE166344T1 (de) | 1998-06-15 |
Family
ID=26228128
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT91401857T ATE166344T1 (de) | 1990-07-05 | 1991-07-04 | Schwefelderivate von imidazol, verfahren zu ihrer herstellung, zwischenprodukte, ihre verwendung als arzneimittel und sie enthaltende pharmazeutische zusammensetzungen |
Country Status (21)
| Country | Link |
|---|---|
| US (3) | US5412101A (de) |
| EP (1) | EP0465368B1 (de) |
| JP (2) | JP3192171B2 (de) |
| KR (1) | KR100216006B1 (de) |
| CN (1) | CN1045769C (de) |
| AT (1) | ATE166344T1 (de) |
| AU (1) | AU653160B2 (de) |
| CA (1) | CA2046265C (de) |
| DE (1) | DE69129428T2 (de) |
| DK (1) | DK0465368T3 (de) |
| ES (1) | ES2117001T3 (de) |
| FI (1) | FI111542B (de) |
| HU (1) | HU217444B (de) |
| IE (1) | IE912335A1 (de) |
| IL (1) | IL98319A (de) |
| MA (1) | MA22203A1 (de) |
| MX (1) | MX9100092A (de) |
| OA (1) | OA09506A (de) |
| RU (1) | RU2086542C1 (de) |
| UA (1) | UA26130A (de) |
| WO (1) | WO2004074258A1 (de) |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5616599A (en) * | 1991-02-21 | 1997-04-01 | Sankyo Company, Limited | Angiotensin II antagosist 1-biphenylmethylimidazole compounds and their therapeutic use |
| FR2687674B1 (fr) * | 1992-02-07 | 1995-05-19 | Roussel Uclaf | Nouveaux derives de la pyridone, leur procede de preparation, les nouveaux intermediaires obtenus, leur application a titre de medicaments et les compositions pharmaceutiques les renfermant. |
| DK0573218T3 (da) * | 1992-06-02 | 2001-06-18 | Sankyo Co | 4-carboxyimidazolderivater som angiotensin-II antagonister og deres terapeutiske anvendelse |
| GB9213934D0 (en) * | 1992-06-30 | 1992-08-12 | Smithkline Beecham Corp | Chemical compounds |
| GB9218449D0 (en) | 1992-08-29 | 1992-10-14 | Boots Co Plc | Therapeutic agents |
| IT1255461B (it) * | 1992-07-28 | 1995-11-02 | Luso Farmaco Inst | Eteri di imidazoli ad attivita' a ii antagonista |
| US5376666A (en) * | 1992-11-30 | 1994-12-27 | The Du Pont Merck Pharmaceutical Company | Angiotension-II receptor blocking, azacycloalkyl or azacycloalkenyl |
| RU2109736C1 (ru) * | 1992-12-17 | 1998-04-27 | Санкио Компани Лимитед | Производные бифенила и способ их получения |
| FR2711367B1 (fr) * | 1993-10-19 | 1995-12-01 | Roussel Uclaf | Nouveau procédé de préparation de dérivés soufrés de l'imidazole et les nouveaux intermédiaires obtenus. |
| US5395844A (en) * | 1993-06-10 | 1995-03-07 | The Du Pont Merck Pharmaceutical Company | Imidazole 5-position substituted angiotensin II antagonists |
| US5409926A (en) * | 1993-07-19 | 1995-04-25 | Merck & Co., Inc. | AT-2 antagonist inhibition of vascular restenosis |
| FR2711368B1 (fr) * | 1993-09-16 | 1996-01-05 | Roussel Uclaf | Nouveau procédé de préparation de dérivés soufrés de l'imidazole et les nouveaux intermédiaires obtenus. |
| FR2716882B1 (fr) * | 1994-03-04 | 1996-04-05 | Roussel Uclaf | Utilisation de dérivés de l'imidazole au traitement d'affections impliquant les récepteurs AT1 et AT2 de l'Angiotensine, certains de ces produits, leur préparation, compositions pharmaceutiques. |
| HUT77357A (hu) * | 1994-09-26 | 1998-03-30 | Shionogi & Co. Ltd. | AIDS-ellenes imidazolszármazékok és ilyen vegyületeket tartalmazó gyógyászati készítmények |
| EP0855392A3 (de) | 1997-01-22 | 2000-01-05 | Hoechst Aktiengesellschaft | Fünfgliedrige Heterocyclen mit Biphenylsulfonylsubstitution, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
| DE19739113A1 (de) * | 1997-09-06 | 1999-03-11 | Gefinex Polymerschaeume Gmbh | Vorexpandierte polyolefinische Schaumpartikel |
| DE19820064A1 (de) * | 1998-05-06 | 1999-11-11 | Hoechst Marion Roussel De Gmbh | Substituierte Sulfonylcyanamide, Verfahren zu ihrer Herstellung und ihre Verwendung als Medikament |
| SE9903028D0 (sv) | 1999-08-27 | 1999-08-27 | Astra Ab | New use |
| KR20010048940A (ko) * | 1999-11-30 | 2001-06-15 | 서평원 | 프로세서의 디바이스 제어 시스템 |
| IL160253A0 (en) * | 2001-08-09 | 2004-07-25 | Ono Pharmaceutical Co | Carboxylic acid derivative compounds and drugs comprising these compounds as the active ingredient |
| EP1752450A1 (de) | 2005-08-01 | 2007-02-14 | Merck Sante | Imidazolderivate als Fruktose-1,6-biphosphataseinhibitoren und pharmazeutische Zusammensetzungen diese enthaltend |
| ES2559319T3 (es) | 2007-06-04 | 2016-02-11 | Synergy Pharmaceuticals Inc. | Agonistas de guanilato cliclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros trastornos |
| US8034782B2 (en) | 2008-07-16 | 2011-10-11 | Synergy Pharmaceuticals, Inc. | Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders |
| US8969514B2 (en) | 2007-06-04 | 2015-03-03 | Synergy Pharmaceuticals, Inc. | Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases |
| US7828840B2 (en) | 2007-11-15 | 2010-11-09 | Med Institute, Inc. | Medical devices and methods for local delivery of angiotensin II type 2 receptor antagonists |
| EP2328910B1 (de) | 2008-06-04 | 2014-08-06 | Synergy Pharmaceuticals Inc. | Für die behandlung von gastrointestinalen erkrankungen, entzündungen, krebs und anderen erkrankungen geeignete agonisten von guanylatcyclase |
| US8236843B2 (en) | 2008-09-02 | 2012-08-07 | Elder Pharmaceuticals Ltd. | Anti inflammatory compounds |
| US9616097B2 (en) | 2010-09-15 | 2017-04-11 | Synergy Pharmaceuticals, Inc. | Formulations of guanylate cyclase C agonists and methods of use |
| AU2014235215A1 (en) | 2013-03-15 | 2015-10-01 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase and their uses |
| WO2014151200A2 (en) | 2013-03-15 | 2014-09-25 | Synergy Pharmaceuticals Inc. | Compositions useful for the treatment of gastrointestinal disorders |
| BR112015030326A2 (pt) | 2013-06-05 | 2017-08-29 | Synergy Pharmaceuticals Inc | Agonistas ultrapuros de guanilato ciclase c, método de fabricar e usar os mesmos |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4179512A (en) * | 1977-03-01 | 1979-12-18 | Merck & Co., Inc. | 4-Substituted-2-arylimidazoles |
| PT78388B (en) * | 1983-04-12 | 1986-09-15 | Smithkline Beckman Corp | Dopamine-beta-hydroxylase inhibitors |
| CA1334092C (en) * | 1986-07-11 | 1995-01-24 | David John Carini | Angiotensin ii receptor blocking imidazoles |
| US4882348A (en) * | 1987-12-29 | 1989-11-21 | Smithkline Beckman Corporation | 2-(aminoalkylthio)imidazoles as dopamine-β-hydroxylase inhibitors |
| CA1338238C (en) * | 1988-01-07 | 1996-04-09 | David John Carini | Angiotensin ii receptor blocking imidazoles and combinations thereof with diuretics and nsaids |
-
1991
- 1991-05-31 IL IL98319A patent/IL98319A/xx not_active IP Right Cessation
- 1991-07-03 MA MA22476A patent/MA22203A1/fr unknown
- 1991-07-04 DK DK91401857T patent/DK0465368T3/da active
- 1991-07-04 AT AT91401857T patent/ATE166344T1/de not_active IP Right Cessation
- 1991-07-04 HU HU265/91A patent/HU217444B/hu not_active IP Right Cessation
- 1991-07-04 EP EP91401857A patent/EP0465368B1/de not_active Expired - Lifetime
- 1991-07-04 KR KR1019910011310A patent/KR100216006B1/ko not_active Expired - Fee Related
- 1991-07-04 UA UA5001537A patent/UA26130A/uk unknown
- 1991-07-04 RU SU915001537A patent/RU2086542C1/ru not_active IP Right Cessation
- 1991-07-04 IE IE233591A patent/IE912335A1/en not_active IP Right Cessation
- 1991-07-04 WO PCT/FR1991/000543 patent/WO2004074258A1/fr not_active Ceased
- 1991-07-04 US US07/838,289 patent/US5412101A/en not_active Expired - Lifetime
- 1991-07-04 AU AU80163/91A patent/AU653160B2/en not_active Ceased
- 1991-07-04 FI FI913250A patent/FI111542B/fi not_active IP Right Cessation
- 1991-07-04 DE DE69129428T patent/DE69129428T2/de not_active Expired - Fee Related
- 1991-07-04 ES ES91401857T patent/ES2117001T3/es not_active Expired - Lifetime
- 1991-07-04 CA CA002046265A patent/CA2046265C/fr not_active Expired - Fee Related
- 1991-07-05 CN CN91105292A patent/CN1045769C/zh not_active Expired - Fee Related
- 1991-07-05 MX MX9100092A patent/MX9100092A/es active IP Right Grant
- 1991-07-05 JP JP19114491A patent/JP3192171B2/ja not_active Expired - Fee Related
- 1991-07-05 OA OA60035A patent/OA09506A/fr unknown
-
1995
- 1995-01-09 US US08/369,909 patent/US5599830A/en not_active Expired - Fee Related
-
1996
- 1996-10-09 US US08/723,471 patent/US5684028A/en not_active Expired - Fee Related
-
2000
- 2000-10-18 JP JP2000317651A patent/JP3261403B2/ja not_active Expired - Lifetime
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE166344T1 (de) | Schwefelderivate von imidazol, verfahren zu ihrer herstellung, zwischenprodukte, ihre verwendung als arzneimittel und sie enthaltende pharmazeutische zusammensetzungen | |
| DE69230449D1 (de) | N-substituierte Chinolinderivate, Verfahren zur Herstellung, ihre Verwendung als Arzneimittel und diese enthaltende pharmazeutische Zusammensetzungen | |
| DE59103595D1 (de) | Neue phospholipid-derivate von nucleosiden, deren herstellung sowie deren verwendung als antivirale arzneimittel. | |
| ES8802220A1 (es) | Procedimiento para la obtencion de amidas de acidos benzoheterociclilalcanoicos. | |
| MY101721A (en) | 6-vinyl-furo-(3,4-c)-pyridine derivatives | |
| GR1001597B (el) | Νέα βιολογικώς δραστικά παράγωγα εμπουρναμενίνης, φαρμακευτικές συν?έσεις οι οποίες περιέχουν αυτά και μέ?οδος δια την παρασκευή αυτών. | |
| NO812355L (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 3,1-benzoksazin-2-on-derivater | |
| DK0553016T3 (da) | Hidtil ukendte naphtalenamider og -sulfonamider, fremgangsmåder til deres fremstilling samt farmaceutiske midler indeholdende dem | |
| DK0564358T3 (da) | 3-aminochroman-spiro-derivater, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende sådanne | |
| AU583125B2 (en) | Improvements in or relating to pyrazoles | |
| ATE36854T1 (de) | Tetrahydrothienopyridine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel. | |
| YU82493A (sh) | Novi postupak za dobivanje sumpornih derivata imidazola i dobiveni intermedijeri | |
| ES8604897A1 (es) | Procedimiento para la obtencion de 1-(2-oxiaminocarbonilfe- nilsulfonil)-3-heteroaril-ureas | |
| FI940030A0 (fi) | Uusi menetelmä imidatsolin rikkijohdannaisten valmistamiseksi ja uusiavälituotteita | |
| MY113529A (en) | New derivatives of imidazole n- benzyldioxole,processes for their preparation, their use as medicaments and pharmaceutical compositions containing them | |
| AU2175083A (en) | 2-(substituted amino)-pyrimid-4-one derivatives | |
| ATE22284T1 (de) | 2-aminomethyl-6-sulfamoylphenolderivate, verfahren zu ihrer herstellung, ihre verwendung sowie pharmazeutische praeparate auf basis dieser verbindungen. | |
| ES2017633B3 (es) | Amido derivados. | |
| ATE73818T1 (de) | Verfahren zur herstellung von peptiden unter der verwendung von perchloraten. | |
| MX9700821A (es) | Nueva utilizacion y derivados novedosos del imidazol, su procedimiento de preparacion, los nuevos intermediarios obtenidos, su aplicacion a manera de medicamentos y las composiciones farmaceuticas que los incluyen. | |
| ES8604941A1 (es) | Procedimiento para la obtencion de benzodisultamas | |
| ATE55768T1 (de) | Substituierte alkylamino-derivate von 6,11dihydro-11-oxo-dibenz(b,e)-oxepin, verfahren zu ihrer herstellung, ihre zwischenprodukte und ihre verwendung als arzneimittel. | |
| NO942051L (no) | Nye tiosemikarbazontioner | |
| MX9709955A (es) | Derivados del acido 5-pirazolilbenzoico. | |
| IT8448979A1 (it) | Uso dell'acido ialuronico come veicolo per farmaci oftalmici e composizioni farmaceutiche contenenti questa sostanza. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |